Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clinical Genomics, |
RCV002464012 | SCV002605424 | pathogenic | Maturity onset diabetes mellitus in young | criteria provided, single submitter | research | Potent mutations in GCK gene is associated with poor secretion of insulin. Its associated with milder forms of diabetes, which can be controlled by diet . However, there is no sufficient evidence to ascertain the significance of rs878853246 in MODY, yet. | |
Labcorp Genetics |
RCV002516247 | SCV003225463 | pathogenic | not provided | 2022-08-20 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 236192). This premature translational stop signal has been observed in individual(s) with clinical features of GCK-related conditions (PMID: 26669242). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln38*) in the GCK gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GCK are known to be pathogenic (PMID: 7553875, 9867845, 14578306, 24323243, 25015100). |
Shenzhen Institute of Pediatrics, |
RCV000225041 | SCV000282026 | pathogenic | Maturity-onset diabetes of the young type 2 | 2016-04-13 | no assertion criteria provided | clinical testing |